Common Chronic Care Issues

Decor

Program Details

  • Intended Audience:  Pharmacists interested in Common Chronic Care Issues
  • Universal Activity Number: 0012-0000-22-028-H01-P
  • Contact Hours: 6.0 Consultant Recertification/General hours of ACPE continuing education for pharmacists
  • Program Fees:
    • Regular Registration: $110.00
    • UF Preceptor/Career Coach: $90.00
    • UF COP Faculty: $80.00
  • UAN Release Date: 07/01/2022
  • UAN Expiration Date: 07/01/2025
  • Activity Type: Knowledge
  • Program Support: No outside financial support was provided.
  • Format Type: This course is self-paced, fully online.
  • Time to Complete: All coursework must be completed within 24 weeks from the date of registration or before date of UAN expiration, 07/01/2025, whichever comes first. This course will no longer be eligible for CE credit after 07/01/2025.

Summary

Metabolic Syndrome is a group of conditions that when found in the same person increase the risk of coronary artery disease, stroke and other health conditions.  The conditions most closely associated with this syndrome are hypertension, hyperlipidemia, diabetes and obesity. These also happen to be some of the most common chronic care conditions we treat as pharmacists. The goal of this program is to review these conditions and their treatments so as to better understand how they fit into the overall risk picture for metabolic syndrome.

This course is approved by the Florida Board of Pharmacy for 6.0 contact hours to meet requirements pursuant to CHAPTER 64B16-26, Florida Statutes, and Rule 64B16-26.300, Florida Administrative Code.


Objectives

Doctor showing vial to patient

At the completion of this activity, the participant will be able to:

  • Describe metabolic syndrome as a cluster of several disorders that together raise the risk of individuals developing atherosclerotic cardiovascular disease, insulin resistance, diabetes mellitus, and can lead to vascular and neurologic complications.
  • Explain the prevalence of metabolic syndrome and epidemiological and statistical data.
  • Discuss the rationale for the treatment and management of these related conditions to decrease the risk of metabolic complications and improve patient outcomes.

Program Overview

Lecture 1: Overview of Metabolic Syndrome

Upon completion of this lecture, you should be able to:

  • Describe metabolic syndrome as a cluster of several disorders that together raise the risk of individuals developing atherosclerotic cardiovascular disease, insulin resistance, diabetes mellitus, and can lead to vascular and neurologic complications.
  • Explain the prevalence of metabolic syndrome and epidemiological and statistical data.
  • Discuss the rationale for the treatment and management of these related conditions to decrease the risk of metabolic complications and improve patient outcomes.

Lecture 2: Hyperlipidemia

Upon completion of this lecture, you should be able to:

  • Perform patient assessments.
  • Evaluate and manage diseases and health conditions, including appropriate drug therapy changes, in collaboration with other health care practitioner.
  • Order, perform, and interpret clinical and laboratory tests related to collaborative pharmacy practice.

Lecture 3: Hypertension

Upon completion of this lecture, you should be able to:

  • Review updated definitions and goals from the 2017 AHA/ACC hypertension guidelines.
  • Perform patient assessment for a patient with hypertension.
  • Order, perform, and interpret clinical and laboratory testing for a patient with hypertension.
  • Evaluate and manage hypertension, including drug therapy changes in collaboration with other health care providers.

Lecture 4: Pharmacological Management of Diabetes and Weight Loss

Upon completion of this lecture, you should be able to:

  • Identify potential complications associated with obesity.
  • Analyze a patient to determine if they are a candidate for pharmacotherapy treatment of obesity.
  • Recommend treatment options for obesity in both children and adults and discuss the risks and benefits of each treatment.

Lecture 5: Type 2 Diabetes Mellitus

Upon completion of this lecture, you should be able to:

  • Perform patient assessments for patients with Type 2 Diabetes Mellitus (T2DM).
  • Order, perform, and interpret clinical and laboratory tests related to collaborative pharmacy practice for patients with T2DM.
  • Evaluate and manage T2DM, including appropriate drug therapy changes, in collaboration with other health care practitioners.

Lecture 6: Continuous Glucose Monitoring for Patients with Type 2 Diabetes

Upon completion of this lecture, you should be able to:

  • Define continuous blood glucose monitoring and indications for use in patients with type 2 diabetes.
  • Review glycemic treatment targets for patients with type 2 diabetes.
  • Compare and contrast self-monitored blood glucose monitoring and continuous blood glucose monitoring.
  • Summarize glucose monitoring devices available for blood glucose monitoring.
  • Evaluate results of continuous blood glucose monitoring, including appropriate drug therapy changes, in collaboration with other health care practitioners.

Requirements for Successful Course Completion

In order to earn credit for this course, participants must pass a final assessment with a score of 70% or higher. Two chances to pass the assessment will be given. If a passing score is not earned by the second attempt, the participant must re-enroll in the course. Upon successful completion of all coursework, participants must complete a course evaluation form.


Course Access

To access your course after enrollment, please click the link below.

http://elearning.ufl.edu/

Click the blue “Log in to Continuing Education” button and enter your login credentials. You should then see your course on the Canvas dashboard or by clicking Courses>All Courses.


Disclosure Statement

Eric A Dietrich, Pharm.D., BCACP, CPC-A, CEMC, CPB (speaker) has disclosed that he receives an unrestricted Investigator-initiated Research Grant from BMS/Pfizer. All of the relevant financial relationships listed for Dr. Dietrich have been mitigated. No other speaker, reviewer, or planning committee member in a position to control content has any financial relationships to disclose.

Eric A Dietrich
Department: Pharmacotherapy & Translational Research

Eric A Dietrich Pharm.D., BCACP, CPC-A, CEMC, CPB

Associate Professor
Michelle Z Farland
Department: Pharmacotherapy & Translational Research

Michelle Z Farland Pharm.D.

Clinical Professor And Interim Co-Chair
Carol A Motycka
Department: Jacksonville Campus

Carol A Motycka Pharm.D., BCACP

Assistant Dean For The Jacksonville Campus; Clinical Professor
Rachel Shaddock
Department: Pharmacotherapy & Translational Research

Rachel Shaddock

Resident
Bradley W Van Riper
Department: Continuing Education

Bradley W Van Riper Pharm.D.

POST DOC ASO

Additional Resources

Please review the resources below before registering for the course.


ACPE logo

The University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.